Skip to main content
Glanbia Plc logo

Glanbia Plc — Investor Relations & Filings

Ticker · GL9 ISIN · IE0000669501 LEI · 635400SRMCBHVMSKJS84 IR Manufacturing
Open in API
Filings indexed 2,260 across all filing types
Latest filing 2024-04-02 Declaration of Voting R…
Country IE Ireland
Listing IR GL9

About Glanbia Plc

https://www.glanbia.com/

Glanbia Plc is a global nutrition company focused on developing and marketing a portfolio of consumer brands and nutritional ingredients. The company's operations are centered on two key areas: Performance Nutrition and Nutritional Solutions. The Performance Nutrition segment provides a range of products, such as powders and ready-to-eat formats, designed to support active lifestyles and athletic performance under various consumer brands. The Nutritional Solutions division serves as an innovation partner to the global food industry, supplying custom-formulated, science-led ingredient solutions, particularly dairy and plant-based proteins, for use in food, beverage, and supplement products. The company aims to deliver products with tangible nutritional benefits to help consumers feel strong and perform well.

Recent filings

Filing Released Lang Actions
Total Voting Rights
Declaration of Voting Results & Voting Rights Announcements Classification · 100% confidence The document explicitly states the 'TOTAL VOTING RIGHTS' as of a specific date (31 March 2024) and provides the total number of ordinary shares in issue (264,127,000). It references compliance with the Transparency Directive regulations, which mandates the disclosure of total voting rights. This content directly relates to the calculation denominator for shareholder notification regarding ownership changes. This aligns perfectly with the definition of 'Declaration of Voting Results & Voting Rights Announcements' (DVA), as it declares the total voting rights figure.
2024-04-02 English
Total Voting Rights
Declaration of Voting Results & Voting Rights Announcements Classification · 100% confidence The document is a short announcement identified by the 'RNS Number' and the source being 'RNS, the news service of the London Stock Exchange'. The content explicitly states the 'TOTAL VOTING RIGHTS' as of a specific date (31 March 2024) and provides the total number of ordinary shares (264,127,000). This type of regulatory disclosure regarding the total number of shares and voting rights, often used as a denominator for shareholder notification calculations under transparency directives, does not fit neatly into the primary financial report categories (10-K, IR, ER). It is a specific regulatory update. While it relates to share capital, it is primarily a mandatory disclosure of voting rights. Given the options, this is best classified as a general regulatory announcement, which aligns with the 'Regulatory Filings' (RNS) category, as it is a standard, short-form disclosure provided via the RNS system.
2024-04-02 English
Transaction in Own Shares
Transaction in Own Shares Classification · 100% confidence The document explicitly states in the title and body that it concerns a 'Transaction in Own Shares' by Glanbia plc, detailing the number of ordinary shares purchased, the prices paid, and referencing a 'Buy-Back Programme'. This directly aligns with the definition for 'Transaction in Own Shares' (Code: POS), which covers the company buying back or selling its own shares (share repurchase/issuance). The document is a formal announcement detailing the transaction, not a general regulatory filing (RNS) or a report publication announcement (RPA), as it contains the substantive data itself.
2024-04-02 English
Transaction in Own Shares
Transaction in Own Shares Classification · 100% confidence The document explicitly details the purchase of ordinary shares by Glanbia plc on Euronext Dublin, including the number of shares, highest/lowest/VWAP prices, and the context of a share buy-back programme. This activity directly corresponds to the definition of 'Transaction in Own Shares'. The presence of the RNS Number and the RNS distribution boilerplate confirms it is a regulatory announcement, but the specific content points directly to the POS code.
2024-04-02 English
Director/PDMR Shareholding
Director's Dealing Classification · 99% confidence The document is explicitly titled 'Notification of Transactions by Persons Discharging Managerial Responsibilities and Persons Closely Associated with them' and references Article 19 of Regulation (EU) No 596/2014 (Market Abuse Regulation). It details share acquisitions and sales by several executives (Ian Doyle, Mark Garvey, Hugh McGuire, Brian Phelan, Susan Sweem) of Glanbia plc. This content directly corresponds to the reporting requirements for insider trading or executive share dealings. Among the provided codes, 'Director's Dealing' (DIRS) is the most specific match for reports detailing personal share transactions by directors and executives. The presence of the RNS Number and the LSE distribution footer confirms it is a regulatory announcement, but DIRS is more precise than the general RNS code.
2024-03-28 English
Director/PDMR Shareholding
Director's Dealing Classification · 100% confidence The document is titled 'Notification of Transactions by Persons Discharging Managerial Responsibilities and Persons Closely Associated with them' and explicitly references disclosure requirements under 'Article 19 of Regulation (EU) No 596/2014 on market abuse (Market Abuse Regulation)'. This type of filing details personal share transactions by company directors and executives (insider trades). This directly matches the definition for Director's Dealing (DIRS). Although it involves transactions, it is a regulatory disclosure of insider activity, not a general capital change (SHA) or transaction in own shares (POS) by the company itself.
2024-03-28 English

Browse filings by year

16 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.